These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 26516108)

  • 21. Oxidative Stress Product, 4-Hydroxy-2-Nonenal, Induces the Release of Tissue Factor-Positive Microvesicles From Perivascular Cells Into Circulation.
    Ansari SA; Keshava S; Pendurthi UR; Rao LVM
    Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):250-265. PubMed ID: 33028097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelets contribute to the initiation of colitis-associated cancer by promoting immunosuppression.
    Servais L; Wéra O; Dibato Epoh J; Delierneux C; Bouznad N; Rahmouni S; Mazzucchelli G; Baiwir D; Delvenne P; Lancellotti P; Oury C
    J Thromb Haemost; 2018 Apr; 16(4):762-777. PubMed ID: 29369476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism.
    Campello E; Spiezia L; Radu CM; Bulato C; Castelli M; Gavasso S; Simioni P
    Thromb Res; 2011 May; 127(5):473-7. PubMed ID: 21256535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anticoagulant and antithrombotic properties of intracellular protease-activated receptor antagonists.
    Wielders SJ; Bennaghmouch A; Reutelingsperger CP; Bevers EM; Lindhout T
    J Thromb Haemost; 2007 Mar; 5(3):571-6. PubMed ID: 17166251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets.
    Müller I; Klocke A; Alex M; Kotzsch M; Luther T; Morgenstern E; Zieseniss S; Zahler S; Preissner K; Engelmann B
    FASEB J; 2003 Mar; 17(3):476-8. PubMed ID: 12514112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tissue factor: a neglected role in cancer biology.
    Li H; Yu Y; Gao L; Zheng P; Liu X; Chen H
    J Thromb Thrombolysis; 2022 Jul; 54(1):97-108. PubMed ID: 35763169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of clopidogrel treatment on stress-induced platelet activation and myocardial ischemia in aspirin-treated patients with stable coronary artery disease.
    Perneby C; Wallén NH; Hofman-Bang C; Tornvall P; Ivert T; Li N; Hjemdahl P
    Thromb Haemost; 2007 Dec; 98(6):1316-22. PubMed ID: 18064330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting of C-type lectin-like receptor 2 or P2Y12 for the prevention of platelet activation by immunotherapeutic CpG oligodeoxynucleotides.
    Delierneux C; Donis N; Servais L; Wéra O; Lecut C; Vandereyken M; Musumeci L; Rahmouni S; Schneider J; Eble JA; Lancellotti P; Oury C
    J Thromb Haemost; 2017 May; 15(5):983-997. PubMed ID: 28296036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Importance of platelets in experimental venous thrombosis in the rat.
    Herbert JM; Bernat A; Maffrand JP
    Blood; 1992 Nov; 80(9):2281-6. PubMed ID: 1421399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer cell-derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo.
    Thomas GM; Panicot-Dubois L; Lacroix R; Dignat-George F; Lombardo D; Dubois C
    J Exp Med; 2009 Aug; 206(9):1913-27. PubMed ID: 19667060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malignant transformation in melanocytes is associated with increased production of procoagulant microvesicles.
    Lima LG; Oliveira AS; Campos LC; Bonamino M; Chammas R; Werneck C; Vicente CP; Barcinski MA; Petersen LC; Monteiro RQ
    Thromb Haemost; 2011 Oct; 106(4):712-23. PubMed ID: 21800005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between platelet reactivity and circulating platelet-derived microvesicles in patients with acute coronary syndrome.
    Kafian S; Mobarrez F; Wallén H; Samad B
    Platelets; 2015; 26(5):467-73. PubMed ID: 25025694
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and efficacy of targeting platelet proteinase-activated receptors in combination with existing anti-platelet drugs as antithrombotics in mice.
    Lee H; Sturgeon SA; Mountford JK; Jackson SP; Hamilton JR
    Br J Pharmacol; 2012 Aug; 166(7):2188-97. PubMed ID: 22428607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lactadherin and clearance of platelet-derived microvesicles.
    Dasgupta SK; Abdel-Monem H; Niravath P; Le A; Bellera RV; Langlois K; Nagata S; Rumbaut RE; Thiagarajan P
    Blood; 2009 Feb; 113(6):1332-9. PubMed ID: 19023116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between microvesicles bearing monomeric C-reactive protein and platelet reactivity. Relationship with low response to antiplatelet drugs?
    Siennicka A
    J Physiol Pharmacol; 2021 Feb; 72(1):. PubMed ID: 34099580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microparticle bearing tissue factor: a link between promyelocytic cells and hypercoagulable state.
    Gheldof D; Mullier F; Bailly N; Devalet B; Dogné JM; Chatelain B; Chatelain C
    Thromb Res; 2014 Mar; 133(3):433-9. PubMed ID: 24290525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-33 stimulates the release of procoagulant microvesicles from human monocytes and differentially increases tissue factor in human monocyte subsets.
    Stojkovic S; Thulin Å; Hell L; Thaler B; Rauscher S; Baumgartner J; Gröger M; Ay C; Demyanets S; Neumayer C; Huk I; Spittler A; Huber K; Wojta J; Siegbahn A; Åberg M
    Thromb Haemost; 2017 Jun; 117(7):1379-1390. PubMed ID: 28492698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinct Pathogenesis of Pancreatic Cancer Microvesicle-Associated Venous Thrombosis Identifies New Antithrombotic Targets In Vivo.
    Stark K; Schubert I; Joshi U; Kilani B; Hoseinpour P; Thakur M; Grünauer P; Pfeiler S; Schmidergall T; Stockhausen S; Bäumer M; Chandraratne S; von Brühl ML; Lorenz M; Coletti R; Reese S; Laitinen I; Wörmann SM; Algül H; Bruns CJ; Ware J; Mackman N; Engelmann B; Massberg S
    Arterioscler Thromb Vasc Biol; 2018 Apr; 38(4):772-786. PubMed ID: 29419408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of aspirin and clopidogrel on platelet-dependent tissue factor expression in endothelial cells.
    Savi P; Bernat A; Dumas A; Aït-Chek L; Herbert JM
    Thromb Res; 1994 Jan; 73(2):117-24. PubMed ID: 8171410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clopidogrel inhibits platelet-leukocyte adhesion and platelet-dependent leukocyte activation.
    Evangelista V; Manarini S; Dell'Elba G; Martelli N; Napoleone E; Di Santo A; Lorenzet PS
    Thromb Haemost; 2005 Sep; 94(3):568-77. PubMed ID: 16268474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.